Chang, Lijia

Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor

Wei, Y., Chang, L., & Hashimoto, K. (2022) · Molecular Psychiatry

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 248

Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine

Chang, L., Zhang, K., Pu, Y., Qu, Y., Wang, S.-M., Xiong, Z., Ren, Q., Dong, C., Fujita, Y., & Hashimoto, K. (2019) · Pharmacology Biochemistry and Behavior

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 176

Brain-spleen axis in health and diseases: A review and future perspective

Wei, Y., Wang, T., Liao, L., Fan, X., Chang, L., & Hashimoto, K. (2022) · Brain Research Bulletin

Stress Responses and CortisolVagus Nerve Stimulation Research

Cited by 134

Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1

Zhang, K., Yang, C., Chang, L., Sakamoto, A., Suzuki, T., Fujita, Y., Qu, Y., Wang, S., Pu, Y., Tan, Y., et al. (2020) · Translational Psychiatry

Treatment of Major DepressionTryptophan and brain disorders

Cited by 119

Antibiotic-Induced Microbiome Depletion Protects against MPTP-Induced Dopaminergic Neurotoxicity in the Brain

Pu, Y., Chang, L., Qu, Y., Wang, S., Zhang, K., & Hashimoto, K. (2019) · Aging

Parkinson's Disease Mechanisms and TreatmentsGut microbiota and health

Cited by 80

Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine

Zhang, K., Sakamoto, A., Chang, L., Qu, Y., Wang, S., Pu, Y., Tan, Y., Wang, X., Fujita, Y., Ishima, T., et al. (2021) · European Archives of Psychiatry and Clinical Neuroscience

Stress Responses and CortisolTryptophan and brain disorders

Cited by 63

(R)-Ketamine Rapidly Ameliorates the Decreased Spine Density in the Medial Prefrontal Cortex and Hippocampus of Susceptible Mice After Chronic Social Defeat Stress

Zhang, J., Qu, Y., Chang, L., Pu, Y., & Hashimoto, K. (2019) · International Journal of Neuropsychopharmacology

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 55

Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model

Xiong, Z., Fujita, Y., Zhang, K., Pu, Y., Chang, L., Ma, M., Chen, J., & Hashimoto, K. (2019) · Behavioural Brain Research

Treatment of Major DepressionTryptophan and brain disorders

Cited by 49

Intranasal administration of transforming growth factor-β1 elicits rapid-acting antidepressant-like effects in a chronic social defeat stress model: A role of TrkB signaling

Wei, Y., Chang, L., & Hashimoto, K. (2021) · European Neuropsychopharmacology

Treatment of Major DepressionTryptophan and brain disorders

Cited by 30

Gut–microbiota–brain axis in the vulnerability to psychosis in adulthood after repeated cannabis exposure during adolescence

Wan, X., Eguchi, A., Qu, Y., Yang, Y., Chang, L., Shan, J., Mori, C., & Hashimoto, K. (2022) · European Archives of Psychiatry and Clinical Neuroscience

Cannabis and Cannabinoid ResearchGut microbiota and health

Cited by 21